This article discusses Deuterium Capital Management’s top 5 stock picks at the end of June 2022. If you want to know about the fund’s history, its investment strategy, and recent performance, please also read Top 10 Stock Picks of Osman Ozsan’s Deuterium Capital Management.
05. AbbVie Inc. (NYSE:ABBV)
Deuterium Capital Management’s Stake Value: $1.300 million
Percentage of Deuterium Capital Management’s 13F Portfolio: 4.4%
Number of Hedge Fund Holders as of Q1 2022: 76
AbbVie Inc. (NYSE:ABBV) was incorporated in 2012 and is headquartered in North Chicago, Illinois. It discovers, develops, manufactures, and sells pharmaceuticals worldwide.
On August 1, Atlantic Equities analyst Steve Chesney downgraded AbbVie Inc. (NYSE:ABBV) to Neutral from Overweight with a price target of $162, down from $178. The analyst says “incremental weakness” across the company’s core franchises hints at a slowing pace of upward estimate revisions. The stock is a new addition to Deuterium Capital Management’s portfolio, with a total stake value of $1.3 million (4.4% of the portfolio).
04. Microsoft Corporation (NASDAQ:MSFT)
Deuterium Capital Management’s Stake Value: $1.618 million
Percentage of Deuterium Capital Management’s 13F Portfolio: 5.48%
Number of Hedge Fund Holders as of Q1 2022: 259
Deuterium Capital Management’s stake in Microsoft Corporation (NASDAQ:MSFT) during the second quarter remained the same as in the first quarter of 2022.
On July 27, analyst Brad Zelnick of Deutsche Bank decreased his $350 price target for Microsoft Corporation (NASDAQ:MSFT) to $330 while maintaining a Buy rating for the stock. Zelnick informs investors in a research note that although macro pressures that were fully anticipated by investors nevertheless had an impact on the company’s fiscal Q4 results, they were better than feared. Aside from currency, the analyst claims that lower PC supply/demand dynamics in May and June as well as weaker consumer demand had the greatest influence on results.
03. Intuitive Surgical, Inc. (NASDAQ:ISRG)
Deuterium Capital Management’s Stake Value: $3.652 million
Percentage of Deuterium Capital Management’s 13F Portfolio: 12.37%
Number of Hedge Fund Holders as of Q1 2022: 65
Intuitive Surgical, Inc. (NASDAQ:ISRG) was incorporated in 1995 and is headquartered in Sunnyvale, California. It develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally.
On July 22, Truist analyst Richard Newitter lowered the firm’s price target on Intuitive Surgical to $255 from $270 and keeps a Buy rating on the shares. According to the analyst’s research note to investors, the company’s Q2 procedure growth outperformance was offset by weak systems in the face of declining trade-in opportunities and a softening cap-ex expenditure environment. The most significant longer-term driver of system demand, according to Newitter, is procedure growth, which is still growing.
02. Apple Inc. (NASDAQ:AAPL)
Deuterium Capital Management’s Stake Value: $3.691 million
Percentage of Deuterium Capital Management’s 13F Portfolio: 12.5%
Number of Hedge Fund Holders as of Q1 2022: 131
On July 29, Evercore ISI analyst Amit Daryanani raised his price target on Apple to $185 from $180. He keeps an Outperform rating on the shares after the company reported June quarter results which were well ahead of Street fears, given worries around consumer demand.
The stock has a gross profit margin of 43.31% and has lost 1.67% in the past six months and 7.02% year to date. Deuterium Capital Management’s stake in Apple Inc. (NASDAQ:AAPL) during the second quarter remained the same as in the first quarter of 2022.
01. NVIDIA Corporation (NASDAQ:NVDA)
Deuterium Capital Management’s Stake Value: $5.184 million
Percentage of Deuterium Capital Management’s 13F Portfolio: 17.56%
Number of Hedge Fund Holders as of Q1 2022: 102
NVIDIA Corporation (NASDAQ:NVDA) was incorporated in 1993 and is headquartered in Santa Clara, California. The company provides graphics, computing, and networking solutions in the United States, Taiwan, China, and internationally. The company’s products are used in gaming, professional visualization, data center, and automotive markets.
Deuterium Capital Management’s stake in the technology company NVIDIA Corporation (NASDAQ:NVDA) during the second quarter remained the same as in the first quarter of 2022.
You can also check out: Simon Sadler’s Segantii Capital is Bullish on These 10 Stocks and 7 Best Stocks to Buy According to Stephen Feinberg’s Cerberus Capital Management
